US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Gastrointestinal Market Research Reports & Industry Analysis

RSS Feeds

Gastrointestinal Industry Research & Market Reports

6  7  8  9    11    13  14  15  
OTC Pharmaceuticals: Digestive Remedies in Indonesia
5/28/2014 | published by: Euromonitor International
... more incidents of gastric problems. This has accelerated the growth of digestive remedies, specifically antacids. Euromonitor International's Digestive Remedies in Indonesia report offers a comprehensive guide to the size and shape of the market at ...  |  read more...
USD 900
OTC Pharmaceuticals: Digestive Remedies in the United Arab Emirates
5/27/2014 | published by: Euromonitor International
... person in four in the country seeks no treatment whatsoever when experiencing digestive problems such as diarrhoea as they believe that the symptoms are not severe enough to warrant medical intervention or because they mistakenly ...  |  read more...
USD 900
OTC Pharmaceuticals: Digestive Remedies in Ukraine
5/29/2014 | published by: Euromonitor International
... with many consumers. Besides, Ukrainian cuisine is traditionally known as fatty and nourishing with a lot of fat, meat, bread and potatoes consumed. Quality of food in stores is not always the best due to ...  |  read more...
USD 900
Digestive Remedies in Belarus
3/4/2014 | published by: Euromonitor International
... and physical activities continued to increase in 2013. The increasingly hectic lifestyles of urban citizens are also associated with changing nutritional habits away from traditional meals towards on-the-go eating. In addition, smoking, alcohol consumption, and ...  |  read more...
USD 900
Digestive Remedies in Azerbaijan
9/1/2013 | published by: Euromonitor International
... a positive environment for the development of the category. The increasingly hectic pace of life in Azerbaijan is associated with changing nutrition habits and there is a marked shift away from traditional sit-down meals towards ...  |  read more...
USD 900
Digestive Remedies in Nigeria
5/22/2014 | published by: Euromonitor International
... who use digestive remedies to cure ailments caused by poor eating habits, leading to an increase in demand for these products. Furthermore, consumers are increasingly moving away from using herbal/traditional remedies for indigestion due to ...  |  read more...
USD 900
Digestive Remedies - Cameroon
6/18/2014 | published by: Euromonitor International
... for digestive ailments Euromonitor International's Digestive Remedies in Cameroon report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2009-2013, allowing ...  |  read more...
USD 900
Digestive Remedies - the Czech Republic
6/16/2014 | published by: Euromonitor International
... VAT for drugs in the Czech Republic increased from 14% in 2012 to 15% in January 2013. Manufacturers and retailers anticipated the increase and delayed unit price increases, using the rising VAT rate as a ...  |  read more...
USD 900
Digestive Remedies - Slovakia
6/26/2014 | published by: Euromonitor International
... hectic lifestyles were the main reasons for the higher use of digestive remedies. However, some consumers moved towards healthier meals. Thus, the main reason for the increase in the incidence of digestive problems can be ...  |  read more...
USD 900
Pharmaceuticals: Digestive Remedies in Denmark
6/3/2014 | published by: Euromonitor International
... active and interesting lives, combining career with travel, sports and cultural events. Most obviously, the increase in travelling leads to increased sales of motion sickness remedies. Moreover, there is a possibility that hectic lifestyles lead ...  |  read more...
USD 900
Pharmaceuticals: Digestive Remedies in Norway
6/3/2014 | published by: Euromonitor International
... to Europe and regulation arising from that move, Pepcid Duo is expected to return to Norway in 2015. Euromonitor International's Digestive Remedies in Norway report offers a comprehensive guide to the size and shape of ...  |  read more...
USD 900
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 10,995
Uceris (Ulcerative Colitis) - Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the UC market ...  |  read more...
USD 3,495
Xeljanz (Ulcerative Colitis) - Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the UC market ...  |  read more...
USD 3,495
Simponi (Ulcerative Colitis) - Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the UC market ...  |  read more...
USD 3,495
Pentasa (Ulcerative Colitis) - Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the UC market ...  |  read more...
USD 3,495
Kappaproct (Ulcerative Colitis) - Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the UC market ...  |  read more...
USD 3,495
Colazal & Giazo (Ulcerative Colitis) - Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 3,495
PharmaPoint: Ulcerative Colitis - Japan Drug Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 4,995
PharmaPoint: Ulcerative Colitis - US Drug Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 4,995
PharmaPoint: Ulcerative Colitis - Current and Future Players
2/28/2014 | published by: GlobalData
... analysis on the companies in the rapidly growing Ulcerative Colitis Market. The report identifies and analyses the key companies shaping and driving the global Ulcerative Colitis market. The report provides insight into the competitive Ulcerative ...  |  read more...
USD 2,995
Inflammatory Bowel Disease - Pipeline Review, H1 2014
4/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Inflammatory Bowel Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Digestive Remedies Markets in China
6/1/2014 | published by: Asia Market Information & Development Company
... new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and ...  |  read more...
USD 4,000
Nausea - Pipeline Review, H1 2014
5/21/2014 | published by: Global Markets Direct
... Nausea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Infectitious Diarrhea - Pipeline Review, H1 2014
5/21/2014 | published by: Global Markets Direct
... therapeutic development for Infectitious Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
6  7  8  9    11    13  14  15